Table 1. Treatment Groups Groups * .... | American Society of Hematology

Table 1.

Treatment Groups

Groups^*	Time (h)^-151
Groups^*	−48	−36	−24	−12	0	12	24	36	48	60
Controls: PBS 0.1 mL only^-152	+	+	+	+	+		+	+	+	+
G-CSF/pre: 50 μg/kg sc	+	+	+	+
MoAb III/5-1: 10 mg/kg IV					+
G-CSF/pre (×4) + MoAb III/5-1 (×1)	+	+	+	+	+
G-CSF/post: 50 μg/kg sc							+	+	+	+

Groups^*	Time (h)^-151
Groups^*	−48	−36	−24	−12	0	12	24	36	48	60
Controls: PBS 0.1 mL only^-152	+	+	+	+	+		+	+	+	+
G-CSF/pre: 50 μg/kg sc	+	+	+	+
MoAb III/5-1: 10 mg/kg IV					+
G-CSF/pre (×4) + MoAb III/5-1 (×1)	+	+	+	+	+
G-CSF/post: 50 μg/kg sc							+	+	+	+

*pre denotes treatment before induction of pneumonia; post denotes treatment after induction of pneumonia. MoAb III/5-1 was administered 1 hour before induction of pneumonia.

F0-151

Pneumonia was induced at 0 hours by intranasal instillation of 1 × 10³ CFU of K pneumoniae B5055 as described in Materials and Methods.

F0-152

PBS was administered either IV (at −1 hour) or sc (all other time points).

View Large

This Feature Is Available To Subscribers Only